Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Depressive Disorder and CYP3A4[original query] |
---|
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. Pharmacogenomics 2010 Apr 11 (4): 537-46. Tsai Ming-Hsien, Lin Keh-Ming, Hsiao Mei-Chun, Shen Winston W, Lu Mong-Liang, Tang Hwa-Sheng, Fang Chun-Kai, Wu Chi-Shin, Lu Shao-Chun, Liu Shu Chih, Chen Chun-Yu, Liu Yu- |
Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools. The pharmacogenomics journal 2018 5 18 (5): 613-622. Bousman Chad A, Dunlop Boadie |
Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder. Molecular genetics & genomic medicine 2019 Apr e669. ?wiechowski Rafa?, Jele? Agnieszka, Mirowski Marek, Talarowska Monika, Ga?ecki Piotr, Pietrzak Jacek, Wodzi?ski Damian, Balcerczak E |
Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Clinical pharmacology and therapeutics 2019 10 107 (3): 662-670. Qin Sisi, Eugene Andy R, Liu Duan, Zhang Lingxin, Neavin Drew, Biernacka Joanna M, Yu Jia, Weinshilboum Richard M, Wang Liew |
Genotype and Allele Frequency of CYP3A4 -392A>G in Turkish Patients with Major Depressive Disorder. Turkish journal of pharmaceutical sciences 2020 5 15 (2): 200-206. Uçkun Zuhal, Baskak Bora, Özdemir Hatice, Özel-Kizil Erguvan Tu?ba, Devrimci-Özgüven Halise, Süzen Halit Sin |
Frequencies of Genetic Polymorphisms of Clinically Relevant Gene-Drug Pairs in a German Psychiatric Inpatient Population. Pharmacopsychiatry 2020 Dec . Hahn Martina, Müller Daniel J, Roll Sibylle |
Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder. Psychopharmacology bulletin 2021 6 51 (2): 31-42. Zastrozhin M S, Skryabin VYu, Smirnov VYu, Zastrozhina A K, Kaverina E V, Klepikov D A, Grishina E A, Ryzhikova K A, Bure I V, Bryun E A, Sychev D |
Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder. Psychopharmacology bulletin 2021 4 51 (1): 69-80. Zastrozhin M S, Skryabin VYu, Smirnov VYu, Zastrozhina A K, Kaverina E V, Klepikov D A, Grishina E A, Ryzhikova K A, Bure I V, Bryun E A, Sychev D |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: